Search for: "Illumina, Inc. "
Results 141 - 160
of 170
Sort by Relevance
|
Sort by Date
16 Feb 2012, 9:18 am
Illumina, Inc., et al., C.A. [read post]
27 Jan 2012, 8:44 am
Illumina, Inc., C.A. [read post]
26 Jan 2012, 7:14 am
By contrast, the 8-K filed by Intermec Inc. [read post]
26 Jan 2012, 6:40 am
Illumina, Inc., C.A. [read post]
26 Jan 2012, 5:47 am
Illumina Inc., 1-09-cv-00627 (DED January 24, 2012, Order) (Robinson, J.) [read post]
25 Jan 2012, 5:41 am
Hostile Bid: Roche Holding AG offered about $5.7 billion in cash for Illumina Inc. to bolster cancer-drug sales, the third time since 2007 the Swiss drugmaker has made a hostile bid for a U.S. company, Bloomberg reports. [read post]
13 Apr 2011, 8:59 am
White required defendants Illumina, Inc. and Solexa, Inc. [read post]
22 Mar 2011, 4:21 pm
Brownback’s 2010 version (FDA Law Blog) US: Effective March 28, 2011 – New safety reporting requirements for certain drug and biological products (FDA Law Blog) US: FDA issues new guidance on PDUFA user fee waivers, reductions, and refunds; guidance represents the culmination of 18 years of FDA experience (FDA Law Blog) US: Affymetrix files for correction of inventorship: Affymetrix v Illumina (Patent Docs) US: Hoffman-La Roche files for review and correction of patent term… [read post]
3 Feb 2011, 8:24 am
In August, Helicos Biosciences sued Pacific Biosciences of California, Life Technologies and Illumina in Delaware for infringing four patents claiming methods for nucleotide sequencing. [read post]
3 Feb 2011, 8:24 am
In August, Helicos Biosciences sued Pacific Biosciences of California, Life Technologies and Illumina in Delaware for infringing four patents claiming methods for nucleotide sequencing. [read post]
12 Jan 2011, 3:25 pm
Illumina, Inc., C.A. [read post]
23 Dec 2010, 12:42 pm
Illumina Inc., C.A. [read post]
22 Dec 2010, 3:01 am
Inc. [read post]
29 Nov 2010, 11:57 am
Illumina Inc. v. [read post]
10 Aug 2010, 8:44 pm
Highlights this week included: CAFC: Genus-species; doctrine of equivalents; and patentable subject matter: Intervet v Merial Limited (Patently-O) (Holman’s Biotech IP Blog) (IP Spotlight) (IPBiz) (Patent Docs) Angiomax (Bivalirudin) – US: The Medicines Company prevails in patent term extension dispute; USPTO acts quickly to comply with court order (Patent Docs) (Patent Docs) (IPBiz) Skelaxin (Metaxalone) – US: CAFC: Ignoring non-patentable elements while judging novelty:… [read post]
3 Jun 2010, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) General Nature Biotechnology and more anti-gene patenting myths (Patent Docs) Alice de Pastor’s SPC news 2009 (The SPC Blog) US: Sen Kerry introduces Angiomax PTE amendment to Tax Extenders Act of 2009 (FDA Law Blog) US: Blinded… [read post]
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV challenge: Meda… [read post]
25 Mar 2010, 9:59 pm
Illumina, Inc. [read post]
9 Oct 2009, 9:11 am
Illumina Inc. and Solexa Inc. [read post]
28 Aug 2009, 8:11 am
Illumina Inc. [read post]
